The Hale Foundation celebrated 36 years of helping men suffering from substance abuse with a groundbreaking ceremony for a ...

Newcastle returned to success after four losses in a row. Beaten at Brentford (3-0), West Ham relapsed. The thirty-fifth day ...

A committee in the EU recommended that tolebrutinib, to be sold as Cenrifki, be approved for people with SPMS with no relapses for two years.

Recent gambling-related controversies — from personal addiction relapses tied to prediction markets to a high-profile college football betting scandal — are intensifying calls for regulatory reform.

Personalized treatment planning in mental health is evolving, blending evidence-based therapies with individual traits, life context, and collaborative care. From bipolar disorder to depression, ...

Bipolar disorder is a mental health condition estimated to affect between 1% and 3% of people worldwide. Its main symptoms ...

The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...

"We are often seeing the same cycle of anticipation, action and reaction play out again and again,” said Dr. Cynthia Grant, the vice president of clinical for Birches Health.

Only 29% of bipolar disorder patients are prescribed lithium, even though it produces the best clinical results.

Adjuvant therapy improves neither melanoma-specific nor overall survival in patients with stage III disease, conclude Swedish researchers in an updated population-based study.